Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study

BACKGROUND: It has been reported that treatment with uracil-tegafur (UFT) has shown significantly better survival and relapse-free survival (RFS) than surgery alone. Therefore, we compared UFT with a combination therapy of cyclophosphamide, methotrexate, and fluorouracil (CMF) in patients who had un...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Y, Okamura, K, Mitsuyama, S, Saito, T, Koh, J, Kyono, S, Higaki, K, Ogita, M, Asaga, T, Inaji, H, Komichi, H, Kohno, N, Yamazaki, K, Tanaka, F, Ito, T, Nishikawa, H, Osaki, A, Koyama, H, Suzuki, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736822/
https://www.ncbi.nlm.nih.gov/pubmed/19638976
http://dx.doi.org/10.1038/sj.bjc.6605218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736822/
https://www.ncbi.nlm.nih.gov/pubmed/19638976
http://dx.doi.org/10.1038/sj.bjc.6605218

Ejemplares similares